Medicare Enrolled
Dr. Bhupinder Anand, MD
Neurology · Islip, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Anand from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Anand?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Anand
Dr. Bhupinder Anand is a neurology specialist in Islip, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Anand performed 3,119 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Anand received a total of $9,232 from 62 pharmaceutical and/or device companies across 519 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Anand is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 15% volume in NY
$9,232 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,119
Medicare services
Top 15% in NY for neurology
Not available
Unique patients (not deduplicated)
$86
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
698 | $19 | $135 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
273 | $98 | $367 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
255 | $61 | $431 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
164 | $316 | $1,354 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
143 | $73 | $387 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
137 | $136 | $458 |
| Complete ultrasound of brain blood flow An ultrasound test that evaluates blood flow within the brain's blood vessels. It uses sound waves to create images of the vessels and assess circulation. |
127 | $260 | $1,828 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
127 | $1 | $21 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
122 | $82 | $365 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
107 | $15 | $154 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
90 | $0 | $17 |
| New patient office visit, complex (60-74 min) | 85 | $187 | $736 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
80 | $153 | $981 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
78 | $158 | $1,105 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
71 | $35 | $278 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
56 | $8 | $19 |
| Brain blood flow ultrasound with microbubble injection An ultrasound test that uses microbubble injections to visualize blood flow within the brain's blood vessels. This procedure is used to detect blood clots. |
56 | $153 | $1,417 |
| EEG monitoring, 12-26 hours with review This procedure involves monitoring brain wave activity for 12 to 26 hours. A healthcare professional reviews the data and provides a report. |
55 | $142 | $783 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
50 | $0 | $0 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
47 | $31 | $360 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
47 | $1 | $5 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
46 | $110 | $553 |
| Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 38 | $0 | $0 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
37 | $255 | $1,282 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
26 | $13 | $257 |
| Electrocardiogram, 1-3 leads with physician review A heart rhythm test using one to three electrodes to record electrical activity, with interpretation by a physician. |
24 | $12 | $36 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
19 | $141 | $628 |
| Continuous EEG brain wave monitoring A test that records electrical activity in the brain over an extended period. It is used to monitor brain function continuously. |
17 | $168 | $400 |
| EEG monitoring, 12-26 hours This procedure involves monitoring brain wave activity using an electroencephalogram (EEG) for a duration of 12 to 26 hours. |
17 | $146 | $1,000 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
14 | $121 | $619 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
13 | $45 | $244 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
37.7% high complexity
27.9% medium
34.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,232
Total received (2018-2024)
Avg $1,319/year across 7 years
Top 25% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
62
Companies
519
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$16
2023
$1,238
2022
$2,912
2021
$1,580
2020
$268
2019
$1,651
2018
$1,566
Payments by company (2024)
ABBVIE INC.
$16
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$757
Neurocrine Biosciences, Inc.
$584
SK Life Science, Inc.
$561
Novartis Pharmaceuticals Corporation
$550
ABBVIE INC.
$490
Acorda Therapeutics, Inc
$434
AbbVie Inc.
$419
Amgen Inc.
$374
Greenwich Biosciences, Inc.
$359
EMD Serono, Inc.
$337
Sunovion Pharmaceuticals Inc.
$325
Boston Scientific Corporation
$286
ACADIA Pharmaceuticals Inc
$282
Allergan, Inc.
$228
Eisai Inc.
$226
LivaNova USA, Inc.
$209
Grifols USA, LLC
$201
EISAI INC.
$184
Lundbeck LLC
$155
Allergan Inc.
$151
Neurelis, Inc.
$143
Biogen, Inc.
$130
Alexion Pharmaceuticals, Inc.
$126
CSL Behring
$119
Otsuka America Pharmaceutical, Inc.
$101
Avanir Pharmaceuticals, Inc.
$92
Amneal Pharmaceuticals LLC
$85
Kyowa Kirin, Inc.
$78
Collegium Pharmaceutical, Inc.
$70
Neos Therapeutics, LP
$70
Corium, LLC
$68
GENZYME CORPORATION
$66
GE Healthcare
$65
Lilly USA, LLC
$59
Biohaven Pharmaceutical Holding Company Ltd.
$58
Alnylam Pharmaceuticals Inc.
$58
GE HEALTHCARE
$54
Sumitomo Pharma America, Inc.
$54
Shire North American Group Inc
$52
Arbor Pharmaceuticals, Inc.
$49
PFIZER INC.
$44
AstraZeneca Pharmaceuticals LP
$43
Biohaven Pharmaceuticals, Inc.
$37
Impax Laboratories, Inc.
$34
ARBOR PHARMACEUTICALS, INC.
$34
Merz Pharmaceuticals, LLC
$34
Takeda Pharmaceuticals U.S.A., Inc.
$33
Promius Pharma LLC
$26
IMPEL PHARMACEUTICALS INC.
$25
Medtronic USA, Inc.
$24
Teva Pharmaceuticals USA, Inc.
$23
MITSUBISHI TANABE PHARMA AMERICA, INC.
$19
Adamas Pharmaceuticals, Inc.
$19
Scilex Pharmaceuticals Inc.
$17
Ipsen Biopharmaceuticals, Inc
$16
AQUESTIVE THERAPEUTICS, INC.
$16
Supernus Pharmaceuticals, Inc.
$15
Bayer HealthCare Pharmaceuticals Inc.
$15
Bausch Health US, LLC
$15
Almatica Pharma LLC
$13
MDD US Operations, LLC
$13
Endo Pharmaceuticals Inc.
$12
Top 3 companies account for 20.6% of all-time payments
Associated products mentioned in payments ›
ACTIVA · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMPYRA · ANDEXXA · APOKYN · APTIOM · AUBAGIO · Adlarity · Aduhelm · Adzenys XR-ODT · Aimovig · BOTOX · BOTOX THERAPEUTIC · BRILINTA · Betaseron · Briviact · COMIRNATY · Cotempla XR-ODT · DUOPA · DYSPORT · EMGALITY · Epidiolex · FABRAZYME · Fycompa · GAMMAGARD · GOCOVRI · GRALISE · Gamunex-C · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · LYRICA · Leqembi · MIGRANAL · Mavenclad · NASCOBAL · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · Nuedexta · ONFI · ONPATTRO · OXTELLAR XR · Ongentys · QULIPTA · RADICAVA · REXULTI · RYTARY · Rebif · SOLIRIS · SYMPAZAN · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VNS Therapy · VYEPTI · Vyvanse · WATCHMAN Access System · WATCHMAN FLX · XCOPRI · XTAMPZA · Xeomin · ZEMBRACE SYMTOUCH · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zembrace
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
186
County median income
$128,329
Nearest hospital to ZIP centroid (approximate)
NS/LIJ HS SOUTHSIDE HOSPITAL
2.0 mi
2.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Anand is a clinical cardiology specialist, with above-average Medicare volume (top 15% in NY), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Anand experienced with additional hour of intravenous infusion?
Based on Medicare claims data, Dr. Anand performed 698 additional hour of intravenous infusion services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Anand receive payments from pharmaceutical companies?
Yes. Dr. Anand received a total of $9,232 from 62 companies across 519 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Anand's costs compare to other neurologists in Islip?
Dr. Anand's average Medicare payment per service is $86. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Anand) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Islip
Browse neurologists in Islip ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NY
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NY
Which NY neurologists receive the most from drug and device companies.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Neurocrine Biosciences, Inc. Payments to Doctors
See all physicians who received payments from Neurocrine Biosciences, Inc.
By company
SK Life Science, Inc. Payments to Doctors
See all physicians who received payments from SK Life Science, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology